Home
>
National Drug Code (NDC)
>
Clorazepate dipotassium
Clorazepate dipotassium - 63304-552-01 - (Clorazepate dipotassium)
Drug Information of Clorazepate dipotassium
| Product NDC: | 63304-552 |
| Proprietary Name: | Clorazepate dipotassium |
| Non Proprietary Name: | Clorazepate dipotassium |
| Active Ingredient(s): | 3.75 mg/1 & nbsp; Clorazepate dipotassium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clorazepate dipotassium
| Product NDC: | 63304-552 |
| Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076911 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20050114 |
Package Information of Clorazepate dipotassium
| Package NDC: | 63304-552-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (63304-552-01) |
NDC Information of Clorazepate dipotassium
| NDC Code | 63304-552-01 |
| Proprietary Name | Clorazepate dipotassium |
| Package Description | 100 TABLET in 1 BOTTLE (63304-552-01) |
| Product NDC | 63304-552 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clorazepate dipotassium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20050114 |
| Marketing Category Name | ANDA |
| Labeler Name | Ranbaxy Pharmaceuticals Inc. |
| Substance Name | CLORAZEPATE DIPOTASSIUM |
| Strength Number | 3.75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |
